Analytical Cellular Pathology · Published 2025-01-01 · DOI 10.1155/ancp/5595692
Conclusion: Our collective findings advised that circ-ZEB1 takes part in the malignant progression through regulating the miR-491-5p/EIF5A axis, highlighting its potential as an effective NSCLC therapeutic target.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →